Similarly, Zheng et al. revealed that KRT19P3, another lncRNA, potentially inhibits the growth of tumors via COPS7A-mediated NF-κB signals, implying its possible role for GC treatment (Zheng et al., 2019). Here, NFKB1 is linked to gastric cancer.